ELLIPSES PHARMA - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 88490321
Serial Number
88490321
Registration Number
6592661
Word Mark
ELLIPSES PHARMA
Status
700 - Registered
Status Date
2021-12-21
Filing Date
2019-06-26
Registration Number
6592661
Registration Date
2021-12-21
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2021-03-09
Attorney Name
Law Office Assigned Location Code
O10
Employee Name
OJEYEMI, ASHLEY CHRIST
Statements
Disclaimer with Predetermined Text
"PHARMA"
Goods and Services
Pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; anti-cancer preparations; anti-cancer drugs; compounds for treating cancer; biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumour necrosis factors; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; anti-cancer preparations of microbial origin; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations from hormones and antagonists; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; all of the aforesaid for use in oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to cancer
Goods and Services
Medical and surgical apparatus and instruments, namely, instruments for diagnosing and treating cancer; medical analysis devices, namely, medical diagnostic devices for analyzing the presence or extent of cancer, and for monitoring cancer treatments, immunotherapy cancer treatments, radiation therapy cancer treatments, chemotherapy cancer treatments, radiotherapy cancer treatments, targeted cancer therapy treatments in the body, and for analyzing the efficacy of cancer treatments; medical imaging apparatus, namely, devices for cancer imaging; medical scanning apparatus namely, devices for scanning for cancer; apparatus for the diagnosis of cancer; apparatus for use in medical analysis for the diagnosis and treatment of cancer; cell counting units for medical diagnostic use, namely, electrical resistance cell counters, flow cytometers, and microscopic image analyzers; diagnostic apparatus for medical use for testing cancer cells; all of the aforesaid for use in oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to cancer
Goods and Services
Medical and pharmacological research services; biological research, clinical research in the field of cancer and medical research; Providing an on-line network environment featuring technology that enables users to share data for drug and pharmaceutical research and development; Providing an on-line network environment featuring technology that enables users to share data in the field of the design, development and testing of drugs and pharmaceuticals; Providing scientific and technological services, namely, scientific research, analysis, and design relating to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to cancer; design, development and testing of drugs and pharmaceuticals for the treatment and/or prevention of cancer; laboratory research into new drugs and pharmaceutical products; pharmaceutical drug development services; research relating into medicines; consultancy services relating to scientific and medical research in the field of cancer and oncology; expert advice relating to drug development, namely consulting services in the field of drug development; laboratory analysis in the field of oncology; computer hardware and software design and development in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; computer network services namely providing search engines for obtaining information on a global computer network in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; software hosting services, namely, hosting software for use by others for use in relation to medical databases and information, in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; software as a service (SAAS) namely, hosting software for use by others for use in relation to medical databases and information, in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; Information Technology (IT) consultancy, advisory and information services relating to a network of medical research professionals in the technology field of medical information networks and databases; scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology and cancer clinical trials; scientific research projects and studies in the fields of oncology and clinical trials research; conducting clinical trials for others; clinical research in the field of oncology; clinical research in the field of cancer treatments and pharmaceuticals; providing an online network that features technology that enables users to share data for clinical trials; conducting and compiling data for others for research purposes in the field of treatment, cure and prevention of cancer via an online computer network; development of measuring and testing methods in the field of medicine; evaluation of pharmaceutical drug development services of others to assure compliance with industry standards; pharmaceutical product evaluation; pharmaceutical research services; all of the aforesaid in relation to in oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to cancer
Goods and Services
Medical services; medical consultation services; cancer consultation and treatment services, namely, medical diagnosis and treatment of cancer; health care services; health screening services in field of cancer; cancer screening services; managed health care services; pharmaceutical services namely, pharmaceutical advice; providing online medical record services, namely maintaining personal medical history records and files; advisory and consultancy relating to all of the aforesaid; all of the aforesaid for use in oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to cancer
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-07-06
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2019-07-06
Primary Code
010
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-07-06
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-07-06
Primary Code
044
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
S. Roxanne Edwards
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
United KingdomFalse
False
Trademark Events
Event DateEvent Description
2019-06-29NEW APPLICATION ENTERED IN TRAM
2019-07-06NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-07-23TEAS VOLUNTARY AMENDMENT RECEIVED
2019-07-29ASSIGNED TO LIE
2019-08-01PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
2019-09-05TEAS VOLUNTARY AMENDMENT RECEIVED
2019-09-09PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
2019-09-17ASSIGNED TO EXAMINER
2019-10-02NON-FINAL ACTION WRITTEN
2019-10-02NON-FINAL ACTION E-MAILED
2019-10-02NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-04-02TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-04-02CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-04-03TEAS/EMAIL CORRESPONDENCE ENTERED
2020-06-23FINAL REFUSAL WRITTEN
2020-06-23FINAL REFUSAL E-MAILED
2020-06-23NOTIFICATION OF FINAL REFUSAL EMAILED
2020-12-21TEAS REQUEST FOR RECONSIDERATION RECEIVED
2020-12-21CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-12-21TEAS/EMAIL CORRESPONDENCE ENTERED
2021-01-06TEAS CHANGE OF OWNER ADDRESS RECEIVED
2021-01-06TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2021-01-06ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2021-01-06TEAS CHANGE OF CORRESPONDENCE RECEIVED
2021-01-06APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2021-01-08PREVIOUS ACTION COUNT WITHDRAWN
2021-01-07ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
2021-01-07TEAS CHANGE OF OWNER ADDRESS RECEIVED
2021-01-07TEAS CHANGE OF CORRESPONDENCE RECEIVED
2021-01-07APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2021-01-07REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
2021-01-15NOTICE OF REINSTATEMENT E-MAILED
2021-01-28APPROVED FOR PUB - PRINCIPAL REGISTER
2021-01-29ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
2021-02-01ELECTRONIC RECORD REVIEW COMPLETE
2021-02-17NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-03-09PUBLISHED FOR OPPOSITION
2021-03-09OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-05-04NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2021-11-03TEAS POST PUBLICATION AMENDMENT RECEIVED
2021-11-17CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-11-03NOTICE OF ALLOWANCE CANCELLED
2021-11-171(B) BASIS DELETED; PROCEED TO REGISTRATION
2021-12-21REGISTERED-PRINCIPAL REGISTER